Multiplex Real time PCR Kit for HPV E6/E7 mRNA Genotyping

Multiplex real-time PCR kit for simultaneous detection and genotyping of human papillomavirus (HPV) E6/E7 mRNA targets. Enables identification of multiple HPV genotypes in a single reaction, supporting cervical cancer screening and risk stratification in clinical laboratories.

Multiplex real-time PCR kit for simultaneous detection and genotyping of 28 HPV types. Enables comprehensive cervical cancer screening and risk stratification through E6/E7 mRNA analysis. Delivers rapid, multiplexed results for clinical HPV surveillance and patient management.

In vitro qualitative detection kit for 15 high-risk HPV E6/E7 mRNA subtypes in cervical exfoliated cell samples. Detects HPV 16, 18, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, 68 for cervical cancer and precancerous lesion risk assessment. NMPA Class III medical device registered.

A fluorescent PCR melting curve method-based detection kit for genotyping Human Papillomavirus through E6/E7 mRNA analysis. This kit enables molecular diagnostics of HPV infections at the mRNA level.

A diagnostic kit for qualitative detection of 15 high-risk HPV E6/E7 mRNA types (16, 18, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, 68) in cervical exfoliated cell samples. The kit detects HPV at the viral gene transcription level, directly reflecting the expression of HR-HPV E6/E7 oncogenic genes, and is closely associated with viral integration and cellular malignant transformation. It can serve as a risk assessment tool for cervical cancer and precancerous lesions, providing accurate information for cervical cancer screening and disease prediction.

A nucleic acid-based PCR test kit for genotyping of human papillomavirus. Provides comprehensive identification of HPV strains for clinical assessment.

This diagnostic kit uses real-time multiple fluorescent PCR technology combined with an Automated Fully Enclosed qPCR Instrument. It is used for in vitro qualitative detection of high-risk HPV16, HPV18, and 16 other high-risk types (HPV26, HPV31, HPV33, HPV35, HPV39, HPV45, HPV51, HPV52, HPV53, HPV56, HPV58, HPV68, HPV59, HPV66, HPV73, and HPV82) in cervical exfoliated cells or reproductive tract secretions. Test results assist in HPV auxiliary diagnosis.

Molecular assay for identifying 14 WHO-defined high-risk HPV types and 4 additional clinically relevant HPV types associated with cervical cancer. Enables comprehensive cervical cancer risk stratification.

A fluorescence PCR-based qualitative detection kit for identifying 15 types of human papillomavirus DNA from cervical or urine samples. Includes CE certification and enables specific genotype differentiation.

Qualitatively detects high-risk human papillomavirus (HPV) DNA in cervical exfoliate cells or urine samples, including types 16, 18, 26, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, 68, 73, and 82, with specific genotyping identification for types 16 and 18. It uses fluorescent PCR technology and has obtained CE certification.

Microarray-based diagnostic test for detection and genotyping of human papillomavirus strains. Manufactured using precision microarray printing technology for reliable clinical detection.

A nucleic acid detection kit designed to identify 14 types of high-risk human papillomavirus (HPV) with specific genotyping for HPV types 16 and 18. This test kit enables comprehensive HPV screening and risk stratification for cervical cancer prevention. The kit provides detailed genotyping information for clinical management and patient counseling.